Come up with a name for your new list and we'll add to it:
NewLink Genetics raised a round of funding on March 20, 2009. Investors include
Qualifying Therapeutic Discovery Project.
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.…